HNSCC cells may have developed a mechanism to prevent TBK1-IRF3 signaling and manipulate (long-term) STING-IKK-NF-κB activation to help produce a negative inflammatory environment that drives disease. This evidence concerns the gene NFKB1 and head and neck squamous cell carcinoma.